These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31514565)

  • 21. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies.
    Kamaluddin M; McNally P; Breatnach F; O'Marcaigh A; Webb D; O'Dell E; Scanlon P; Butler K; O'Meara A
    Acta Paediatr; 2001 Oct; 90(10):1204-7. PubMed ID: 11697438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.
    Lopez-Lopez E; Gutierrez-Camino A; Astigarraga I; Navajas A; Echebarria-Barona A; Garcia-Miguel P; Garcia de Andoin N; Lobo C; Guerra-Merino I; Martin-Guerrero I; Garcia-Orad A
    Pharmacogenomics; 2016 May; 17(7):731-41. PubMed ID: 27180762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.
    Martin-Guerrero I; Gutierrez-Camino A; Echebarria-Barona A; Astigarraga I; Garcia de Andoin N; Navajas A; Garcia-Orad A
    Pharmacogenomics J; 2019 Dec; 19(6):564-569. PubMed ID: 30723315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
    Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
    Yasu T; Ohno N; Kawamata T; Kurokawa Y
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.
    Renbarger JL; McCammack KC; Rouse CE; Hall SD
    Pediatr Blood Cancer; 2008 Apr; 50(4):769-71. PubMed ID: 18085684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
    Jain S; Kapoor G
    Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
    [No Abstract]   [Full Text] [Related]  

  • 29. Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.
    Lieber S; Blankenburg M; Apel K; Hirschfeld G; Hernáiz Driever P; Reindl T
    Eur J Paediatr Neurol; 2018 May; 22(3):457-469. PubMed ID: 29396168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia.
    Joshi J; Tanner L; Gilchrist L; Bostrom B
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):457-462. PubMed ID: 31233464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A cohort study of vincristine-induced peripheral neuropathy in children].
    Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.
    Gilchrist LS; Marais L; Tanner L
    Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy.
    Akbayram S; Akgun C; Doğan M; Sayin R; Caksen H; Oner AF
    Indian J Pediatr; 2010 Jun; 77(6):681-3. PubMed ID: 20532679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
    Teusink AC; Ragucci D; Shatat IF; Kalpatthi R
    Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer.
    Bradfield SM; Sandler E; Geller T; Tamura RN; Krischer JP
    Pediatr Blood Cancer; 2015 Jun; 62(6):1004-10. PubMed ID: 25545757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral vocal cord paralysis following treatment with vincristine.
    Naithani R; Dolai TK; Kumar R
    Indian Pediatr; 2009 Jan; 46(1):68-9. PubMed ID: 19179723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
    Tunjungsari DA; Gunawan PI; Ugrasena IDG
    J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.
    Raj TA; Smith AM; Moore AS
    Int J Nanomedicine; 2013; 8():4361-9. PubMed ID: 24232122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.
    Gutierrez-Camino Á; Umerez M; Martin-Guerrero I; García de Andoin N; Santos B; Sastre A; Echebarria-Barona A; Astigarraga I; Navajas A; Garcia-Orad A
    Pharmacogenomics J; 2018 Dec; 18(6):704-712. PubMed ID: 29282364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.